Sony biotechnology INC:1106976 [17-059015]
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700621P
- Awardee
-
Sony Biotechnology Inc. UEI DQF2MP5BTAW7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,035
Award facts
- Contract value 100% obligated
- $19,035.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Sony Biotechnology Inc. for $19,035.00 on September 7, 2017, with an ultimate completion date of September 20, 2018. No set-aside was used. Work is performed in Bethesda, Maryland. The order is priced on a firm fixed-price basis and procures flow cytometry instrumentation and associated support services. Sony Biotechnology operates as a prime contractor and does not use subcontractors on federal work.
Quick answers
Who was awarded contract HHSN261201700621P?
HHSN261201700621P was awarded to Sony Biotechnology Inc. by National Cancer Institute (National Institutes of Health) on September 7, 2017.
How much is contract HHSN261201700621P worth?
The government has obligated $19,035 on HHSN261201700621P.
Was contract HHSN261201700621P competed?
The extent of competition for HHSN261201700621P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award